Anti-Active Rab11 Mouse Monoclonal Antibody-抗体-抗体-生物在线
Anti-Active Rab11 Mouse Monoclonal Antibody

Anti-Active Rab11 Mouse Monoclonal Antibody

商家询价

产品名称: Anti-Active Rab11 Mouse Monoclonal Antibody

英文名称: Anti-Active Rab11 Mouse Monoclonal Antibody

产品编号: 26919

产品价格: null

产品产地: 美国

品牌商标: NewEastbio

更新时间: null

使用范围: IP, IHC

武汉纽斯特生物技术有限公司
  • 联系人 :
  • 地址 : 武汉市东湖新技术开发区光谷生物城B3-3栋2-3楼
  • 邮编 : 430074
  • 所在区域 : 湖北
  • 电话 : 186****7297
  • 传真 : 027-87561022
  • 邮箱 : neweast3@126.com

Catalog Number:  26919
Gene Symbol:  RAB11
Description:   Anti-Active Rab11 Mouse Monoclonal Antibody
Background:   Small GTPases of the Rab-family are crucial elements of the machinery that controls membrane traffic. Rab11 has been shown to control traffic through the recycling endosome.
Immunogen:   Recombinant full length protein of active Rab11
Applications:   IP, IHC
Recommended Dilutions:   IP: 1 μg for 1~2 mg total cellular proteins
IHC: 1:50~100 dilution
Concentration:   1 mg/ml
Host:   mouse
Format:   Liquid
Clonality:   Monoclonal
Isotype:   IgG2b
Purity:    Purified from ascites
Storage buffer:
Preservative:  no
Constituents:   PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 50% glycerol
Species Reactivity:  Anti-active Rab11 antibody recognizes active Rab11 from vertebrates.
Storage Conditions:  Store at -20°C. Avoid freeze / thaw cycles
 
Immunoprecipitation/Western blot:  
Purified full-length Rab11 proteins were immunoprecipitated after treated with GDP (lane left) or GTPγS (lane right). Immunoprecipitation was done with the anti-active Rab11 monoclonal antibody (Cat. No. 26919). Immunoblot was with an anti-Rab5 polyclonal antibody (Cat. No. 21157).
 
Publications:
1.  VASP promotes TGF-β activation of hepatic stellate cells by regulating Rab11 dependent plasma membrane targeting of TGF-β receptors
    Hepatology Volume 61, Issue 1, pages 361–374, January 2015
2.  Rab5 Activity Regulates GLUT4 Sorting into Insulin-Responsive and Non-Insulin-Responsive Endosomal Compartments: A Potential Mechanism for Development of Insulin Resistance
    Endocrinology. 2014 Sep;155(9):3315-28